Actively Recruiting
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Led by The Geneva Foundation · Updated on 2025-12-10
100
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
Sponsors
T
The Geneva Foundation
Lead Sponsor
B
Brooke Army Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this effort will be to optimize and operationalize innovative passive surveillance systems and in parallel, the effort will identify, evaluate, and transition groundbreaking new technologies in diagnostics for operationalization. To meet the objective and execute the deliverables for this program of effort, the A\&M Breathalyzer PROTECT Kiosk will be tested, modified and validated at Brooke Army Medical Center (BAMC). The collaborative efforts between the PI, Dr. Michael Morris at BAMC and Co-Investigator Dr. Tony Yuan at USU- Center for Biotechnology (4D Bio3) will assess the passive detection technology and provide a capability survey of use-case scenarios for different operational settings. Goals: 1. Optimization and operationalize the A\&M Breathalyzer PROTECT Kiosk, portable mass spectrometer (MS) Detector for Deployment in Military Operational Medicine Environments. The Breathalyzer will be deployed to BAMC to test its detection capabilities of COVID-19 among symptomatic and asymptomatic COVID-19 carrier vs. those not infected compared to gold standard RT-PCR. 2. Evaluate the passive sensing, breath capture system, built within the A\&M Breathalyzer PROTECT Kiosk. The conversion of the active breath capture system, currently requires a straw that the subject breaths into, where then a series of sensors built in the Breathalyzer would automatically sample the exhaled breath within proximity for recent COVID-19 exposure. This task would conclude with a set of sensors and sensor inputs that would be analyzed by the Atomic AI platform built in the device. Field testing at BAMC is planned to determine the level of detection and discrimination for sensor combinations to SARS-CoV2 components and biomarkers detected. This testing would update the Atomic AI algorithm, within the device, to understand the accuracy of positive detection and the resulting sensitivities.
CONDITIONS
Official Title
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Asymptomatic and symptomatic individuals 18 years and older
- Receiving standard COVID-19, Flu and/or RSV screening and testing at Brooke Army Medical Center
- Do not have to be diagnosed with SARS-CoV-19 (COVID-19) but only be screened
- Ability to understand consent
You will not qualify if you...
- Individuals under 18 years of age
- Anyone unable to comply with study procedures or requiring assistance to do so
- Anyone unable to provide a temperature thermal scan or perform exhaled breath for approximately 8 seconds
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brooke Army Medical Center
Fort Sam Houston, Texas, United States, 78234
Actively Recruiting
Research Team
T
Tony Yuan, PhD
CONTACT
K
Katherine Walker-Rodriguez
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here